Were you unable to attend Sugar Soirée 2020?

Did you get outbid in the silent auction? Crinetics would love to keep the spirit of the Sugar Soirée alive on the 2020 CHI Sugar Soirée Vendor Day! When participants/families attend the Crinetics LIVE update on Wednesday 10/28 at 3pm EST – Crinetics will donate to the CHI Sugar Soirée. The more participants/families that attend means a larger donation to CHI Sugar Soirée on behalf of YOU  – the sweetest patients and families.

  • 10 participant/families = $500 donation to CHI Sugar Soirée
  • 25 participants/families = $1000 donation to CHI Sugar Soirée
  • 50 participants/families = $2000 donation to CHI Sugar Soirée

2020 CHI Sugar Soirée Vendor Day

Crinetics is super excited about the developments and updates in our hyperinsulinism program and we are eager to share these with you. We would love to have 50 participants/families attend our live update. Please share this link with other CHI families so that they can register for reminders and continue the spirit of giving at this year’s Sugar Soirée.

Crinetics live update – 3-5pm EST (Live presentation and Q&A 3-3:45)The following team members will be presenting and available after the meeting for Q&A as well as discussions after the meeting (until 5pm EST)

  • Dr. Stephen Betz – VP of Biology
  • Dr. Chris Ferrara Cook – Senior Medical Director
  • Melissa Fowler – Principle Scientist, In Vivo Pharmacology
  • Stephanie Kallay – Director Patient Advocacy
  • Rosa Luo – Senior Director, DMPK and Clinical Pharmacology
  • Eduardo De La Torre Ames – Clinical Trial Manager

About Crinetics

Crinetics is a pharmaceutical company that develops much-needed therapies for people with rare endocrine diseases. We’re here for patients who are eager to find therapies that provide effective disease control and more simplicity in their lives. We partner with healthcare practitioners to ensure we’re solving real problems for them. And we build value in the company for investors by filling real market needs. Whatever brought you here, welcome.

Learn More

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.